Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study.

Nadia M T RoodenrijsPaco M J WelsingMarlies C van der GoesJanneke TekstraFloris P J G LafeberJohannes W G JacobsJacob M van Laar

Published in: Rheumatology (Oxford, England) (2021)

The economic burden of D2T RA is significantly higher than that of non-D2T RA, indicated by higher healthcare utilization and higher annual total costs. Functional disability is a key determinant of higher costs in RA.

Keyphrases

rheumatoid arthritis
healthcare
disease activity
ankylosing spondylitis
interstitial lung disease
systemic lupus erythematosus
systemic sclerosis
social media
health information